This is to Inform you that at the Meeting of the Board of Directors of the Company held today on Tuesday, 15th April 2025 It has further informed that all final call is called up on 08.04.2025 and so now warrants are fully paid up and converted into equity shares of the Company on the preferential basis and allotted as the pdf attached. The meeting commenced at 03:30 P.M. and concluded at 04:00 P.M. : Please take this on your record. This is for your information Thanking You.

pdf

Biogen Pharmachem Industries Ltd.

08 Apr 2025, 04:44PM

0.83

-2.35%

Corp. Note

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

07 Apr 2025

0.83

-2.35%

Company Update

Biogen Pharmachem Industries Ltd - 531752 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

27 Mar 2025

0.83

-2.35%

Corp. Note

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

We wish to inform that the Board of Directors in their meeting held today, i.e., March 27, 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 (Twenty-Five Crore Only) equity share warrants to non-promoters on Preferential Basis at an issue price of Rs. 1.68/- (Rupees one and sixty-eight paise) each upon receipt of other 5% of the total consideration. The above said allotments have been made in accordance with the terms mentioned in the notice of Postal Ballot dated 13.08.2024 and in compliance with the applicable provisions of the Companies Act, 2013 and SEBI (ICDR) Regulations. Disclosures pursuant to the Regulation 30 of the SEBI (LODR) Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is attached as Annexure A. The meeting commenced at 05:00 P.M. and concluded at 05:40 P.M. This is for your information. Thanking You.

pdf

Biogen Pharmachem Industries Ltd.

21 Mar 2025

0.83

-2.35%

SAST

Biogen Pharmachem Industries Ltd - 531752 - Closure of Trading Window

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

21 Mar 2025

0.83

-2.35%

Corp. Note

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

We wish to inform that the Board of Directors in their meeting held today, i.e., March 21, 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 (Twenty-Five Crore Only) equity share warrants to non-promoters on Preferential Basis at an issue price of Rs. 1.68/- (Rupees one and sixty-eight paise) each upon receipt of other 5% of the total consideration. The above said allotments have been made in accordance with the terms mentioned in the notice of Postal Ballot dated 13.08.2024 and in compliance with the applicable provisions of the Companies Act, 2013 and SEBI (ICDR) Regulations. Disclosures pursuant to the Regulation 30 of the SEBI (LODR) Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is attached as Annexure A. The meeting commenced at 04:00 P.M. and concluded at 04:30 P.M. This is for your information.

pdf

Biogen Pharmachem Industries Ltd.

11 Mar 2025

0.83

-2.35%

Corp. Note

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

We wish to inform that the Board of Directors in their meeting held today, i.e., March 11, 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 (Twenty-Five Crore Only) equity share warrants to non-promoters on Preferential Basis at an issue price of Rs. 1.68/- (Rupees one and sixty-eight paise) each upon receipt of other 5% of the total consideration. The above said allotments have been made in accordance with the terms mentioned in the notice of Postal Ballot dated 13.08.2024 and in compliance with the applicable provisions of the Companies Act, 2013 and SEBI (ICDR) Regulations. Disclosures pursuant to the Regulation 30 of the SEBI (LODR) Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is attached as Annexure A. The meeting commenced at 03:30 P.M. and concluded at 04:05 P.M. This is for your information.

pdf

Biogen Pharmachem Industries Ltd.

08 Mar 2025, 02:58PM

0.83

-2.35%

Company Update

Biogen Pharmachem Industries Ltd - 531752 - Updation Of Website Of The Company On Corporate Information

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

07 Mar 2025

0.83

-2.35%

Corp. Note

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

We wish to inform that the Board of Directors in their meeting held today, Le., March 7, 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 (Twenty-Five Crore Only) equity share warrants to nonpromoters on Preferential Basis at an issue price of Rs. 1.68/- (Rupees one and sixty-eight paise) each upon receipt of other 5% of the total consideration. The above said allotments have been made in accordance with the terms mentioned in the notice of Postal Ballot dated 13.08.2024 and in compliance with the applicable provisions of the Companies Act, 2013 and SEBI (ICDR) Regulations. Disclosures pursuant to the Regulation 30 of the SEBI (LODR) Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9,2015 is attached as Annexure A. The meeting commenced at 03:30 P.M. and concluded at 04:00 P.M. This is for your information. Thanking You.

pdf

Is Sun Techno Overseas Ltd. worth buying?

101 Votes:

Buy 74.26%

Sell 10.89%

Hold 14.85%